Gennex Lab.

{
  "main_header": {
    "sid": 930938,
    "name": "Gennex Lab.",
    "stock_name": "Gennex Lab.",
    "full_name": "Gennex Laboratories Ltd",
    "name_url": "stocks-analysis/gennex-lab",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "8.97",
    "chg": -0.08,
    "chgp": "-0.88%",
    "dir": -1,
    "prev_price": "9.05",
    "mcapval": "220.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531739,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE509C01026",
    "curr_date": "Aug 04, 03:30 PM",
    "curr_time": "22:29 PM",
    "last_traded_at": "Aug 04, 03:30 PM IST",
    "bse_nse_vol": "5.74 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 04, 2026",
    "traded_date_str": "2026 08 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/gennex-lab-930938-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Gennex Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gennex-laboratories-ltd-is-rated-sell-4130011",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/GennexLaborator_mojoScore_4130011.png",
        "date": "2026-07-31 10:11:38",
        "description": "Gennex Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 July 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "When is the next results date for Gennex Laboratories Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-gennex-laboratories-ltd-4129223",
        "imagepath": "",
        "date": "2026-07-30 23:17:11",
        "description": "The next results date for Gennex Laboratories Ltd is scheduled for 14 August 2026...."
      },
      {
        "title": "Gennex Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gennex-laboratories-ltd-is-rated-sell-4108932",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/GennexLaborator_mojoScore_4108932.png",
        "date": "2026-07-20 10:10:58",
        "description": "Gennex Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 July 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 20 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Gennex Laboratories Ltd Downgraded to Sell Amid Technical Weakness and Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gennex-laboratories-ltd-downgraded-to-sell-amid-technical-weakness-and-mixed-financial-signals-4094615",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/GennexLaborator_mojoScore_4094615.png",
        "date": "2026-07-09 08:26:36",
        "description": "Gennex Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 8 July 2026. This shift reflects a combination of deteriorating technical indicators, a cautious financial trend outlook, and a re-evaluation of valuation metrics, despite some positive quarterly financial results. The company’s Mojo Score now stands at 46.0, signalling a Sell recommendation, marking a significant change in investor sentiment."
      },
      {
        "title": "Gennex Laboratories Ltd Falls 3.70%: Valuation Shift and Downgrade Shape Weekly Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gennex-laboratories-ltd-falls-370-valuation-shift-and-downgrade-shape-weekly-trend-4088771",
        "imagepath": "",
        "date": "2026-07-04 15:00:05",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>29 Jun:</strong> Week opens at ₹10.55 with moderate volume</p>\n                    <p><strong>30 Jun:</strong> Stock gains 1.61% despite Sensex dip</p>\n                    <p><strong>1 Jul:</strong> Mojo grade downgraded to Sell amid valuation concerns</p>\n                    <p><strong>2 Jul:</strong> Valuation metrics shift from very attractive to attractive</p>\n                    <p><strong>3 Jul:</strong> Week closes at ₹10.16, down 3.70% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">₹10.55</div></div>\n                    <div class=\"sta..."
      },
      {
        "title": "Gennex Laboratories Ltd Downgraded to Sell Amid Valuation and Performance Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gennex-laboratories-ltd-downgraded-to-sell-amid-valuation-and-performance-concerns-4084276",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/GennexLaborator_mojoScore_4084276.png",
        "date": "2026-07-02 08:40:50",
        "description": "Gennex Laboratories Ltd has seen its investment rating downgraded from Hold to Sell, reflecting a complex interplay of valuation improvements, financial trends, quality assessments, and technical factors. Despite some positive quarterly financial results and an attractive valuation relative to peers, the stock’s underperformance against the broader market and mixed fundamental indicators have prompted a cautious stance from analysts."
      },
      {
        "title": "Gennex Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gennex-laboratories-ltd-valuation-shifts-signal-renewed-price-attractiveness-4083742",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/GennexLaborator_valuationdot_4083742.png",
        "date": "2026-07-02 08:04:22",
        "description": "Gennex Laboratories Ltd has seen a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, despite ongoing sector headwinds and a challenging market environment. This recalibration reflects changes in key multiples such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, positioning the micro-cap pharmaceutical player as a more compelling option relative to its peers and historical averages."
      },
      {
        "title": "Gennex Laboratories Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gennex-laboratories-ltd-is-rated-hold-by-marketsmojo-4075775",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/GennexLaborator_mojoScore_4075775.png",
        "date": "2026-06-28 10:10:45",
        "description": "Gennex Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 June 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 28 June 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Gennex Laboratories Ltd Upgraded to Hold on Technical and Financial Improvements",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gennex-laboratories-ltd-upgraded-to-hold-on-technical-and-financial-improvements-4058400",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/GennexLaborator_mojoScore_4058400.png",
        "date": "2026-06-17 08:29:14",
        "description": "Gennex Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators and financial performance. The upgrade, effective from 16 June 2026, is driven by a combination of enhanced technical trends, solid quarterly financial results, attractive valuation metrics, and a stable quality profile, signalling a cautious but optimistic outlook for this micro-cap pharmaceutical player."
      }
    ],
    "total": 186,
    "sid": "930938",
    "stock_news_url": "https://www.marketsmojo.com/news/gennex-laboratories-930938"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "30-Jul-2026",
      "details": "Pursuant to Regulation 47 of SEBI (LODR) Regulations 2015 please find enclosed herewith Newspaper Publication regarding Meeting of the Board of Directors of the Company scheduled to be held on Friday August 14 2026 for adoption of Unaudited (Standalone and Consolidated) Financial Results for the Quarter ended June 30 2026 along with the Limited Review Report of the Statutory Auditors thereon. Notice had been published in both Business Standard and Saksham (Telugu Local) on July 30 2026. We request you to take the above information on record and acknowledge receipt of the same.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30 2026.",
      "datetime": "29-Jul-2026",
      "details": "Gennex Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve 1. The Unaudited Financial Statements (Standalone and Consolidated) for the Quarter ended June 30 2026; 2. Consider the Limited Review Reports of the Statutory Auditor on Standalone and Consolidated Financial Statements for the Quarter ended June 30 2026; 3. Other Business items.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "17-Jul-2026",
      "details": "With reference to the captioned subject matter pursuant to Regulation 74(5) of SEBI (DP) Regulations 2018 we hereby submit the certificate received from the M/s R&D Infotech Private Limited Registrar and Transfer Agent of the Company for the Quarter ended June 30 2026. We request you to take the above information on record and acknowledge the receipt of the same.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "14 Aug 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Gennex Laboratories Ltd has announced <strong>1:10</strong> stock split, ex-date: 14 Dec 09",
          "dt": "2009-12-14",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Gennex Laboratories Ltd has announced <strong>1:2</strong> rights issue, ex-date: 21 Jul 22",
          "dt": "2022-07-21",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Gennex Laboratories Ltd is Rated Sell

2026-07-31 10:11:38

Gennex Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 July 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

When is the next results date for Gennex Laboratories Ltd?

2026-07-30 23:17:11

The next results date for Gennex Laboratories Ltd is scheduled for 14 August 2026....

Read full news article

Gennex Laboratories Ltd is Rated Sell

2026-07-20 10:10:58

Gennex Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 July 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 20 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Gennex Laboratories Ltd Downgraded to Sell Amid Technical Weakness and Mixed Financial Signals

2026-07-09 08:26:36

Gennex Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 8 July 2026. This shift reflects a combination of deteriorating technical indicators, a cautious financial trend outlook, and a re-evaluation of valuation metrics, despite some positive quarterly financial results. The company’s Mojo Score now stands at 46.0, signalling a Sell recommendation, marking a significant change in investor sentiment.

Read full news article

Gennex Laboratories Ltd Falls 3.70%: Valuation Shift and Downgrade Shape Weekly Trend

2026-07-04 15:00:05

Key Events This Week

29 Jun: Week opens at ₹10.55 with moderate volume

30 Jun: Stock gains 1.61% despite Sensex dip

1 Jul: Mojo grade downgraded to Sell amid valuation concerns

2 Jul: Valuation metrics shift from very attractive to attractive

3 Jul: Week closes at ₹10.16, down 3.70% for the week

Week Open

₹10.55

Read full news article

Gennex Laboratories Ltd Downgraded to Sell Amid Valuation and Performance Concerns

2026-07-02 08:40:50

Gennex Laboratories Ltd has seen its investment rating downgraded from Hold to Sell, reflecting a complex interplay of valuation improvements, financial trends, quality assessments, and technical factors. Despite some positive quarterly financial results and an attractive valuation relative to peers, the stock’s underperformance against the broader market and mixed fundamental indicators have prompted a cautious stance from analysts.

Read full news article

Gennex Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-07-02 08:04:22

Gennex Laboratories Ltd has seen a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, despite ongoing sector headwinds and a challenging market environment. This recalibration reflects changes in key multiples such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, positioning the micro-cap pharmaceutical player as a more compelling option relative to its peers and historical averages.

Read full news article

Gennex Laboratories Ltd is Rated Hold by MarketsMOJO

2026-06-28 10:10:45

Gennex Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 June 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 28 June 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Gennex Laboratories Ltd Upgraded to Hold on Technical and Financial Improvements

2026-06-17 08:29:14

Gennex Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators and financial performance. The upgrade, effective from 16 June 2026, is driven by a combination of enhanced technical trends, solid quarterly financial results, attractive valuation metrics, and a stable quality profile, signalling a cautious but optimistic outlook for this micro-cap pharmaceutical player.

Read full news article

View All News